EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers

Ji Hyae Lim, Jae Min Lim, Hyeong Min Lee, Hyun Jung Lee, Dong Wook Kwak, You Jung Han, Moon Young Kim, Sang Hee Jung, Young Ran Kim, Hyun Mee Ryu, Kwang Pyo Kim

Molecular & Cellular Proteomics · 2024-09 · 23 (9) · 100826

DOI: 10.1016/j.mcpro.2024.100826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024-09. Verfasst von Ji Hyae Lim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Smart MEC Healthcare R&D Center, CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Pre-Eclampsia, Biomarkers, Proteome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyung Hee University, Korea Health Industry Development Institute, Ministry of Health and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preeclampsia (PE) is a hypertensive disorder of pregnancy with various clinical symptoms. However, traditional markers for the disease including high blood pressure and proteinuria are poor indicators of the related adverse outcomes. Here, we performed systematic proteome profiling of plasma samples obtained from pregnant women with PE to identify clinically effective diagnostic biomarkers. Proteome profiling was performed using TMT-based liquid chromatography-mass spectrometry (LC-MS/MS) followed by subsequent verification by multiple reaction monitoring (MRM) analysis on normal and PE maternal plasma samples. Functional annotations of differentially expressed proteins (DEPs) in PE were predicted using bioinformatic tools. The diagnostic accuracies of the biomarkers for PE were estimated according to the area under the receiver-operating characteristics curve (AUC). A total of 1307 proteins were identified, and 870 proteins of them were quantified from plasma samples. Significant differences were evident in 138 DEPs, including 71 upregulated DEPs and 67 downregulated DEPs in the PE group, compared with those in the control group. Upregulated proteins were significantly associated with biological processes including platelet degranulation, proteolysis, lipoprotein metabolism, and cholesterol efflux. Biological processes including blood coagulation and acute-phase response were enriched for down-regulated proteins. Of these, 40 proteins were subsequently validated in an independent cohort of 26 PE patients and 29 healthy controls. APOM, LCN2, and QSOX1 showed high diagnostic accuracies for PE detection (AUC >0.9 and p < 0.001, for all) as validated by MRM and ELISA. Our data demonstrate that three plasma biomarkers, identified by systematic proteomic profiling, present a possibility for the assessment of PE, independent of the clinical characteristics of pregnant women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaBiomarkersProteomeHumansFemalePregnancyAdultProteomicsTandem Mass SpectrometryChromatography, LiquidLipocalin-2Case-Control Studies

Stichwörter der Autor:innen

LC-MS/MSbiomarkersplasmapreeclampsiaproteomics

Substanzen

BiomarkersProteomeLipocalin-2

Autor:innen und Institutionen

  • Smart MEC Healthcare R&D Center, CHA Future Medicine Research Institute, CHA Bundang Medical Center, Seongnam, Republic of Korea.
  • Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, Republic of Korea.
  • Department of Obstetrics & Gynecology, CHA Ilsan Medical Center, CHA University, Gyeonggi-do, Republic of Korea.
  • Department of Obstetrics and Gynecology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea.
  • Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University School of Medicine, Seoul, Republic of Korea.

Förderung

  • Kyung Hee University
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare

Zitieren

APA

Lim, J. H., Lim, J. M., Lee, H. M., Lee, H. J., Kwak, D. W., Han, Y. J., Kim, M. Y., Jung, S. H., Kim, Y. R., Ryu, H. M., & Kim, K. P. (2024). Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers. Molecular & Cellular Proteomics, 23(9), 100826. https://doi.org/10.1016/j.mcpro.2024.100826

Vancouver

Lim JH, Lim JM, Lee HM, Lee HJ, Kwak DW, Han YJ, et al. Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers. Molecular & Cellular Proteomics. 2024;23(9):100826. doi:10.1016/j.mcpro.2024.100826

BibTeX
@article{Lim2024,
  author = {Lim, Ji Hyae and Lim, Jae Min and Lee, Hyeong Min and Lee, Hyun Jung and Kwak, Dong Wook and Han, You Jung and Kim, Moon Young and Jung, Sang Hee and Kim, Young Ran and Ryu, Hyun Mee and Kim, Kwang Pyo},
  title = {Systematic Proteome Profiling of Maternal Plasma for Development of Preeclampsia Biomarkers},
  journal = {Molecular & Cellular Proteomics},
  year = {2024},
  volume = {23},
  number = {9},
  pages = {100826},
  doi = {10.1016/j.mcpro.2024.100826}
}
Kostenlos starten →